16-Jan-2026
TipRanks (Thu, 15-Jan 6:10 AM ET)
DocGo Announces Upcoming Participation at 28th Annual Needham Growth Conference
Business Wire (Mon, 5-Jan 7:35 AM ET)
Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights
Globe Newswire (Thu, 18-Dec 1:15 PM ET)
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the DocGo Securities Litigation
Business Wire (Tue, 16-Dec 8:00 AM ET)
HALPER SADEH LLC ENCOURAGES DOCGO INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
PRNewswire (Fri, 5-Dec 3:25 PM ET)
DocGo Announces Participation at Upcoming December Investor Conferences
Business Wire (Wed, 26-Nov 7:35 AM ET)
DocGo Announces Participation at Upcoming Investor Conferences
Business Wire (Thu, 13-Nov 7:35 AM ET)
DocGo Announces Third Quarter 2025 Results
Business Wire (Mon, 10-Nov 4:05 PM ET)
DocGo Announces Upcoming Launch of Longitudinal Care Services for Major California Health Plan
Business Wire (Tue, 4-Nov 7:35 AM ET)
DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025
Business Wire (Mon, 27-Oct 7:35 AM ET)
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
Docgo trades on the NASDAQ stock market under the symbol DCGO.
As of January 16, 2026, DCGO stock price declined to $0.83 with 1,271,617 million shares trading.
DCGO has a beta of 1.66, meaning it tends to be more sensitive to market movements. DCGO has a correlation of 0.12 to the broad based SPY ETF.
DCGO has a market cap of $81.39 million. This is considered a Micro Cap stock.
Last quarter Docgo reported $71 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.17.
In the last 3 years, DCGO traded as high as $10.82 and as low as $.83.
The top ETF exchange traded funds that DCGO belongs to (by Net Assets): VTI, IWM, VXF, IWN, SCHA.
DCGO has underperformed the market in the last year with a price return of -80.5% while the SPY ETF gained +18.1%. DCGO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.8% and -6.3%, respectively, while the SPY returned +5.0% and +1.2%, respectively.
DCGO support price is $.86 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCGO shares will trade within this expected range on the day.